AxoGen, Inc. (AXGN)
USD 17.04
(-3.67%)
USD 17.04
(-3.67%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | -13.32 Million USD | 36.58% |
| 2022 | -23.47 Million USD | -19.72% |
| 2021 | -20.88 Million USD | -6.04% |
| 2020 | -19.27 Million USD | 24.63% |
| 2019 | -26.21 Million USD | -33.24% |
| 2018 | -20.33 Million USD | -165.35% |
| 2017 | -7.41 Million USD | 3.86% |
| 2016 | -7.69 Million USD | 14.21% |
| 2015 | -8.99 Million USD | 6.33% |
| 2014 | -9.59 Million USD | -1.9% |
| 2013 | -9.41 Million USD | -26.22% |
| 2012 | -7.46 Million USD | -11.47% |
| 2011 | -6.56 Million USD | -266.11% |
| 2010 | -1.82 Million USD | -111.44% |
| 2009 | 15.97 Million USD | 1645.84% |
| 2008 | -1.03 Million USD | -32.92% |
| 2007 | -777.64 Thousand USD | -109.09% |
| 2006 | -371.91 Thousand USD | -21.35% |
| 2005 | -306.48 Thousand USD | -449.53% |
| 2004 | 87.68 Thousand USD | 113.02% |
| 2003 | -1.09 Million USD | 64.01% |
| 2002 | -1.86 Million USD | 72.73% |
| 2001 | -6.86 Million USD | -241.52% |
| 2000 | -2.49 Million USD | -101.02% |
| 1999 | -1.98 Million USD | -433.33% |
| 1998 | -900 Thousand USD | -90.91% |
| 1997 | 400 Thousand USD | 725.0% |
| 1996 | 400 Thousand USD | -50.0% |
| 1995 | 500 Thousand USD | -33.33% |
| 1994 | 900 Thousand USD | 20.0% |
| 1993 | 1.4 Million USD | -23.08% |
| 1992 | 1.2 Million USD | 18.18% |
| 1991 | 1.5 Million USD | 66.67% |
| 1990 | 900 Thousand USD | 0.0% |
| 1989 | 900 Thousand USD | -10.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q2 | 1.63 Million USD | 167.66% |
| 2024 Q1 | -2.66 Million USD | -1124.37% |
| 2023 Q1 | -6.17 Million USD | -35.16% |
| 2023 Q2 | -6.13 Million USD | 0.76% |
| 2023 Q3 | -2.62 Million USD | 57.22% |
| 2023 FY | - USD | 36.58% |
| 2023 Q4 | -1.34 Million USD | 48.88% |
| 2022 Q3 | -3.63 Million USD | 46.09% |
| 2022 Q4 | -4.57 Million USD | -25.65% |
| 2022 FY | - USD | -19.72% |
| 2022 Q1 | -10.12 Million USD | -131.32% |
| 2022 Q2 | -6.74 Million USD | 33.37% |
| 2021 Q4 | -4.37 Million USD | 20.85% |
| 2021 Q2 | -6.13 Million USD | -24.44% |
| 2021 Q1 | -4.93 Million USD | -14.04% |
| 2021 Q3 | -5.53 Million USD | 9.86% |
| 2021 FY | - USD | -6.04% |
| 2020 Q1 | -7.65 Million USD | -8.95% |
| 2020 FY | - USD | 24.63% |
| 2020 Q2 | -8.07 Million USD | -5.42% |
| 2020 Q3 | -145 Thousand USD | 98.2% |
| 2020 Q4 | -4.32 Million USD | -2882.07% |
| 2019 Q3 | -5.43 Million USD | 21.87% |
| 2019 Q1 | -9.53 Million USD | -62.61% |
| 2019 Q2 | -6.95 Million USD | 27.05% |
| 2019 FY | - USD | -33.24% |
| 2019 Q4 | -7.03 Million USD | -29.39% |
| 2018 Q2 | -4.46 Million USD | 6.91% |
| 2018 Q1 | -4.79 Million USD | -164.45% |
| 2018 Q3 | -4.61 Million USD | -3.34% |
| 2018 FY | - USD | -165.35% |
| 2018 Q4 | -5.86 Million USD | -27.15% |
| 2017 Q4 | -1.81 Million USD | -34.02% |
| 2017 FY | - USD | 3.86% |
| 2017 Q2 | -1.33 Million USD | 56.74% |
| 2017 Q3 | -1.35 Million USD | -1.55% |
| 2017 Q1 | -3.07 Million USD | -13.34% |
| 2016 FY | - USD | 14.21% |
| 2016 Q4 | -2.71 Million USD | -153.15% |
| 2016 Q2 | -1.5 Million USD | 41.04% |
| 2016 Q3 | -1.07 Million USD | 28.56% |
| 2016 Q1 | -2.54 Million USD | 3.95% |
| 2015 Q3 | -1.83 Million USD | 11.53% |
| 2015 Q1 | -2.49 Million USD | 5.81% |
| 2015 FY | - USD | 6.33% |
| 2015 Q4 | -2.65 Million USD | -44.18% |
| 2015 Q2 | -2.07 Million USD | 16.6% |
| 2014 Q2 | -2.25 Million USD | 23.71% |
| 2014 FY | - USD | -1.9% |
| 2014 Q1 | -2.95 Million USD | -8.16% |
| 2014 Q3 | -1.74 Million USD | 22.4% |
| 2014 Q4 | -2.64 Million USD | -51.46% |
| 2013 FY | - USD | -26.22% |
| 2013 Q4 | -2.72 Million USD | -21.63% |
| 2013 Q3 | -2.24 Million USD | -3.97% |
| 2013 Q2 | -2.15 Million USD | 5.65% |
| 2013 Q1 | -2.28 Million USD | -3.22% |
| 2012 Q4 | -2.21 Million USD | -21.94% |
| 2012 Q3 | -1.81 Million USD | -20.66% |
| 2012 Q2 | -1.5 Million USD | 18.84% |
| 2012 Q1 | -1.85 Million USD | 5.64% |
| 2012 FY | - USD | -11.47% |
| 2011 Q4 | -1.96 Million USD | 17.52% |
| 2011 FY | - USD | -266.11% |
| 2011 Q1 | 1.49 Million USD | 387.9% |
| 2011 Q2 | 517.3 Thousand USD | -65.33% |
| 2011 Q3 | -2.38 Million USD | -560.97% |
| 2010 FY | - USD | -111.44% |
| 2010 Q4 | -518.34 Thousand USD | 14.71% |
| 2010 Q1 | -369.73 Thousand USD | -102.3% |
| 2010 Q2 | -332.94 Thousand USD | 9.95% |
| 2010 Q3 | -607.74 Thousand USD | -82.54% |
| 2009 FY | - USD | 1645.84% |
| 2009 Q1 | -128.65 Thousand USD | -10.73% |
| 2009 Q2 | 145.27 Thousand USD | 212.92% |
| 2009 Q3 | -125.95 Thousand USD | -186.7% |
| 2009 Q4 | 16.08 Million USD | 12873.21% |
| 2008 Q4 | -116.18 Thousand USD | 79.97% |
| 2008 Q2 | -175.53 Thousand USD | -8.4% |
| 2008 Q1 | -161.93 Thousand USD | -552.56% |
| 2008 FY | - USD | -32.92% |
| 2008 Q3 | -580.01 Thousand USD | -230.43% |
| 2007 Q4 | -24.81 Thousand USD | 94.65% |
| 2007 Q3 | -463.66 Thousand USD | -179.61% |
| 2007 Q2 | -165.82 Thousand USD | -34.43% |
| 2007 Q1 | -123.34 Thousand USD | 28.16% |
| 2007 FY | - USD | -109.09% |
| 2006 FY | - USD | -21.35% |
| 2006 Q4 | -171.7 Thousand USD | -208.26% |
| 2006 Q3 | -55.7 Thousand USD | 44.12% |
| 2006 Q2 | -99.68 Thousand USD | -122.33% |
| 2006 Q1 | -44.83 Thousand USD | -131.02% |
| 2005 Q3 | -14.95 Thousand USD | 75.94% |
| 2005 FY | - USD | -449.53% |
| 2005 Q4 | 144.51 Thousand USD | 1066.43% |
| 2005 Q2 | -62.14 Thousand USD | 83.38% |
| 2005 Q1 | -373.88 Thousand USD | -299.67% |
| 2004 Q1 | 170.67 Thousand USD | 361.49% |
| 2004 Q3 | -117.48 Thousand USD | -246.42% |
| 2004 Q4 | 187.25 Thousand USD | 259.38% |
| 2004 Q2 | 80.23 Thousand USD | -52.99% |
| 2004 FY | - USD | 113.02% |
| 2003 Q3 | 51.15 Thousand USD | 27.64% |
| 2003 Q4 | -62.67 Thousand USD | 69.27% |
| 2003 Q1 | -152.39 Thousand USD | 79.42% |
| 2003 FY | - USD | 64.01% |
| 2003 Q2 | -294.07 Thousand USD | -186.33% |
| 2002 Q2 | -567.01 Thousand USD | 7.16% |
| 2002 FY | - USD | 72.73% |
| 2002 Q3 | -192.1 Thousand USD | 65.6% |
| 2002 Q4 | -496.64 Thousand USD | -155.25% |
| 2002 Q1 | -610.97 Thousand USD | 0.0% |
| 2001 Q3 | -1.08 Million USD | 81.87% |
| 2001 FY | - USD | -241.52% |
| 2001 Q1 | -373.75 Thousand USD | 19.66% |
| 2001 Q2 | -1.67 Million USD | -1494.01% |
| 2000 FY | - USD | -101.02% |
| 2000 Q2 | -628.38 Thousand USD | -50.16% |
| 2000 Q1 | -429.85 Thousand USD | 15.25% |
| 2000 Q4 | -999.33 Thousand USD | -17.4% |
| 2000 Q3 | -398.54 Thousand USD | 37.72% |
| 1999 Q1 | -200 Thousand USD | 50.0% |
| 1999 Q2 | -200 Thousand USD | 0.0% |
| 1999 Q3 | -500 Thousand USD | -150.0% |
| 1999 Q4 | -500 Thousand USD | 0.0% |
| 1999 FY | - USD | -433.33% |
| 1998 FY | - USD | -90.91% |
| 1998 Q3 | - USD | 300.0% |
| 1998 Q4 | -400 Thousand USD | -300.0% |
| 1998 Q2 | - USD | 0.0% |
| 1998 Q1 | -100 Thousand USD | -200.0% |
| 1997 Q1 | 1.9 Million USD | 2000.0% |
| 1997 FY | - USD | 725.0% |
| 1997 Q4 | 100 Thousand USD | -75.0% |
| 1997 Q3 | 400 Thousand USD | -55.56% |
| 1997 Q2 | 400 Thousand USD | -52.63% |
| 1996 FY | - USD | -50.0% |
| 1996 Q3 | 300 Thousand USD | 0.0% |
| 1996 Q4 | - USD | -133.33% |
| 1996 Q2 | 300 Thousand USD | -40.0% |
| 1996 Q1 | 500 Thousand USD | 200.0% |
| 1995 Q3 | 300 Thousand USD | 400.0% |
| 1995 Q1 | 500 Thousand USD | 150.0% |
| 1995 FY | - USD | -33.33% |
| 1995 Q4 | -500 Thousand USD | -266.67% |
| 1995 Q2 | -100 Thousand USD | -120.0% |
| 1994 Q1 | 300 Thousand USD | 0.0% |
| 1994 Q3 | 200 Thousand USD | 0.0% |
| 1994 FY | - USD | 20.0% |
| 1994 Q4 | 200 Thousand USD | 0.0% |
| 1994 Q2 | 200 Thousand USD | -33.33% |
| 1993 FY | - USD | -23.08% |
| 1993 Q3 | 600 Thousand USD | 50.0% |
| 1993 Q4 | 300 Thousand USD | -50.0% |
| 1993 Q1 | 300 Thousand USD | 100.0% |
| 1993 Q2 | 400 Thousand USD | 100.0% |
| 1992 Q2 | 300 Thousand USD | -25.0% |
| 1992 Q4 | 100 Thousand USD | -75.0% |
| 1992 Q3 | 400 Thousand USD | 33.33% |
| 1992 Q1 | 400 Thousand USD | 0.0% |
| 1992 FY | - USD | 18.18% |
| 1991 Q1 | 200 Thousand USD | -33.33% |
| 1991 Q4 | 400 Thousand USD | 0.0% |
| 1991 FY | - USD | 22.22% |
| 1991 Q3 | 400 Thousand USD | 33.33% |
| 1991 Q2 | 400 Thousand USD | 50.0% |
| 1990 FY | - USD | 28.57% |
| 1990 Q2 | -2.9 Million USD | -220.83% |
| 1990 Q1 | 2.2 Million USD | 60.0% |
| 1990 Q4 | 300 Thousand USD | 0.0% |
| 1990 Q3 | 400 Thousand USD | 110.34% |
| 1989 Q1 | 1.6 Million USD | -5.88% |
| 1989 FY | - USD | -30.0% |
| 1989 Q4 | 1.5 Million USD | 400.0% |
| 1989 Q3 | 300 Thousand USD | 107.32% |
| 1989 Q2 | -4.1 Million USD | -356.25% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Acutus Medical, Inc. | -13.48 Million USD | 1.179% |
| Cerus Corporation | -26.53 Million USD | 49.774% |
| OrthoPediatrics Corp. | -8.38 Million USD | -59.026% |
| PetVivo Holdings, Inc. | -10.49 Million USD | -27.0% |
| Talis Biomedical Corporation | -66.04 Million USD | 79.82% |
| Vivos Therapeutics, Inc. | -16.67 Million USD | 20.072% |
| Inogen, Inc. | -45.67 Million USD | 70.822% |
| Spectral AI, Inc. | -12.26 Million USD | -8.694% |
| Nano-X Imaging Ltd. | -47.69 Million USD | 72.055% |
| CVRx, Inc. | -38.73 Million USD | 65.588% |
| DIH Holding US, Inc. Warrants | -3.52 Million USD | -277.778% |
| Helius Medical Technologies, Inc. | -12.1 Million USD | -10.085% |
| Orthofix Medical Inc. | -86.98 Million USD | 84.678% |
| Venus Concept Inc. | -26.11 Million USD | 48.96% |
| Accelerate Diagnostics, Inc. | -49.77 Million USD | 73.221% |
| Bioventus Inc. | -23.07 Million USD | 42.228% |
| BrainsWay Ltd. | -2.31 Million USD | -476.72% |
| Envoy Medical, Inc. | -18.23 Million USD | 26.922% |
| electroCore, Inc. | -17.76 Million USD | 24.955% |
| IceCure Medical Ltd | -15.25 Million USD | 12.62% |
| Lucid Diagnostics Inc. | -49.75 Million USD | 73.211% |
| Monogram Orthopaedics, Inc. | -16.85 Million USD | 20.929% |
| MaxCyte, Inc. | -44.12 Million USD | 69.797% |
| NeuroOne Medical Technologies Corporation | -11.75 Million USD | -13.372% |
| Nexalin Technology, Inc. | -5.69 Million USD | -134.151% |
| PAVmed Inc | -75.74 Million USD | 82.403% |
| Rapid Micro Biosystems, Inc. | -53.75 Million USD | 75.207% |
| RxSight, Inc. | -41.03 Million USD | 67.522% |
| Sight Sciences, Inc. | -49.41 Million USD | 73.028% |
| SI-BONE, Inc. | -34.44 Million USD | 61.308% |
| TELA Bio, Inc. | -40.63 Million USD | 67.199% |
| TriSalus Life Sciences, Inc. | -58.29 Million USD | 77.138% |
| Treace Medical Concepts, Inc. | -39 Million USD | 65.833% |
| LivaNova PLC | 39.01 Million USD | 134.16% |
| 908 Devices Inc. | -34.02 Million USD | 60.829% |
| Alphatec Holdings, Inc. | -110.59 Million USD | 87.948% |
| Nemaura Medical Inc. | -7.28 Million USD | -82.9% |
| NeuroPace, Inc. | -22.83 Million USD | 41.631% |
| LENSAR, Inc. | -8.71 Million USD | -52.949% |
| Apyx Medical Corporation | -18.11 Million USD | 26.413% |
| Cutera, Inc. | -136.56 Million USD | 90.24% |
| STRATA Skin Sciences, Inc. | -3.38 Million USD | -294.32% |
| BioSig Technologies, Inc. | -28.15 Million USD | 52.655% |
| Anika Therapeutics, Inc. | 2.51 Million USD | 629.73% |
| ClearPoint Neuro, Inc. | -20.98 Million USD | 36.5% |
| Integra LifeSciences Holdings Corporation | 383.56 Million USD | 103.475% |
| Axonics, Inc. | 7.77 Million USD | 271.421% |
| Outset Medical, Inc. | -153.78 Million USD | 91.334% |
| IRIDEX Corporation | -7.44 Million USD | -78.947% |
| PROCEPT BioRobotics Corporation | -98.09 Million USD | 86.413% |
| IRadimed Corporation | 20.8 Million USD | 164.075% |
| Tivic Health Systems, Inc. | -8.06 Million USD | -65.319% |
| INVO Bioscience, Inc. | -6.88 Million USD | -93.72% |
| Telesis Bio, Inc. | -40.49 Million USD | 67.086% |
| Viemed Healthcare, Inc. | 36.67 Million USD | 136.339% |
| Varex Imaging Corporation | 67.2 Million USD | 119.833% |
| Quipt Home Medical Corp. | 44.07 Million USD | 130.242% |
| Inspira Technologies Oxy B.H.N. Ltd. | -10.87 Million USD | -22.613% |
| Pulmonx Corporation | -55.09 Million USD | 75.808% |
| Dynatronics Corporation | -976 Thousand USD | -1265.563% |
| Modular Medical, Inc. | -17.1 Million USD | 22.072% |
| ReShape Lifesciences Inc. | -14.48 Million USD | 7.988% |
| Semler Scientific, Inc. | 23.58 Million USD | 156.501% |
| InMode Ltd. | 196.28 Million USD | 106.79% |
| Bruker Corporation | 599 Million USD | 102.225% |
| Cytosorbents Corporation | -28.81 Million USD | 53.74% |
| DexCom, Inc. | 916.7 Million USD | 101.454% |
| Align Technology, Inc. | 799.03 Million USD | 101.668% |
| Viveve Medical, Inc. | -20.61 Million USD | 35.354% |
| ZimVie Inc. | 91.07 Million USD | 114.634% |
| Movano Inc. | -29.12 Million USD | 54.239% |
| Cytek Biosciences, Inc. | -4.4 Million USD | -202.359% |
| Nexalin Technology, Inc. | -5.69 Million USD | -134.151% |
| DIH Holdings US, Inc. Class A Common Stock | -3.52 Million USD | -277.778% |
| Tandem Diabetes Care, Inc. | -194.65 Million USD | 93.153% |
| Profound Medical Corp. | -27.12 Million USD | 50.862% |
| Insulet Corporation | 323.6 Million USD | 104.119% |
| enVVeno Medical Corporation | -25.01 Million USD | 46.726% |
| Surmodics, Inc. | 1.18 Million USD | 1221.886% |
| iCAD, Inc. | -6.56 Million USD | -103.016% |
| Nuwellis, Inc. | -16.35 Million USD | 18.513% |
| Biotricity, Inc. | -8.82 Million USD | -50.97% |
| iRhythm Technologies, Inc. | -96.86 Million USD | 86.24% |
| Aethlon Medical, Inc. | -11.84 Million USD | -12.481% |
| InspireMD, Inc. | -20.91 Million USD | 36.263% |
| PAVmed Inc. | -75.74 Million USD | 82.403% |
| BIOLASE, Inc. | -15.13 Million USD | 11.962% |
| Beyond Air, Inc. | -59.03 Million USD | 77.422% |
| FONAR Corporation | 28.25 Million USD | 147.176% |
| Vivani Medical, Inc. | -26.6 Million USD | 49.91% |
| Tactile Systems Technology, Inc. | 24.54 Million USD | 154.309% |
| Inari Medical, Inc. | 7.11 Million USD | 287.375% |
| UFP Technologies, Inc. | 72.74 Million USD | 118.322% |
| QT Imaging Holdings, Inc. | -3.38 Million USD | -293.646% |
| Heart Test Laboratories, Inc. | -6.15 Million USD | -116.504% |
| Tenon Medical, Inc. | -15.52 Million USD | 14.168% |
| Autonomix Medical, Inc. Common Stock | -15.26 Million USD | 12.695% |
| Co-Diagnostics, Inc. | -41.47 Million USD | 67.866% |
| AdaptHealth Corp. | -171.09 Million USD | 92.21% |
| Sintx Technologies, Inc. | -6.6 Million USD | -101.939% |
| NanoVibronix, Inc. | -3.43 Million USD | -288.006% |
| Quanterix Corporation | -38.08 Million USD | 65.007% |
| Inspira Technologies Oxy B.H.N. Ltd. | -10.87 Million USD | -22.613% |
| Sensus Healthcare, Inc. | 30 Thousand USD | 44526.667% |
| Pacific Biosciences of California, Inc. | -277.28 Million USD | 95.193% |
| TransMedics Group, Inc. | -7.6 Million USD | -75.299% |
| ReWalk Robotics Ltd. | -21.76 Million USD | 38.764% |
| NeuroMetrix, Inc. | -7.09 Million USD | -87.829% |
| Hyperfine, Inc. | -47.06 Million USD | 71.679% |
| Establishment Labs Holdings Inc. | -58.3 Million USD | 77.142% |
| Biomerica, Inc. | -5.99 Million USD | -122.393% |
| Bone Biologics Corporation | 479.57 Thousand USD | 2879.145% |
| AVITA Medical, Inc. | -39.56 Million USD | 66.316% |
| Bluejay Diagnostics, Inc. | -9.17 Million USD | -45.297% |
| Silk Road Medical, Inc | -45.08 Million USD | 70.435% |